KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Molina Healthcare (MOH) Net Income towards Common Stockholders (2016 - 2026)

Molina Healthcare has reported Net Income towards Common Stockholders over the past 17 years, most recently at $14.0 million for Q1 2026.

  • Quarterly Net Income towards Common Stockholders fell 95.3% to $14.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $188.0 million through Mar 2026, down 84.01% year-over-year, with the annual reading at $472.0 million for FY2025, 59.97% down from the prior year.
  • Net Income towards Common Stockholders was $14.0 million for Q1 2026 at Molina Healthcare, up from -$160.0 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $326.0 million in Q3 2024 and troughed at -$160.0 million in Q4 2025.
  • The 5-year median for Net Income towards Common Stockholders is $253.0 million (2024), against an average of $218.2 million.
  • Biggest five-year swings in Net Income towards Common Stockholders: skyrocketed 60.84% in 2022 and later tumbled 163.75% in 2025.
  • Tracing MOH's Net Income towards Common Stockholders over 5 years: stood at $230.0 million in 2022, then dropped by 6.09% to $216.0 million in 2023, then rose by 16.2% to $251.0 million in 2024, then tumbled by 163.75% to -$160.0 million in 2025, then soared by 108.75% to $14.0 million in 2026.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods came in at $14.0 million, -$160.0 million, and $79.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.